Canada’s trusted source for timely news and information on biosimilar biologics
Canada’s trusted source for timely news and information on biosimilar biologics
Stay tuned on this page for more resources and tools. We welcome your comments at feedback@jointhealth.org.
External Resources
Health Canada
Canadian Agency for Drugs and Technologies in Health (CADTH)
Biosimilar Drugs: Your Questions Answered
CADTH Backgrounder on Biosimilars for Health Care Providers
Canadian Institute for Health Information
Prescribed Drug Spending in Canada, 2019: A Focus on Public Drug Programs. Ottawa, ON: CIHI; 2019. https://www.cihi.ca/sites/default/files/document/pdex-report-2019-en-web.pdf
Patented Medicines Prices Review Board
Potential Savings from Biosimilars in Canada
Ontario Drug Policy Research Network
Current and Prospective Utilization of Innovator Biologics and Biosimilars in Ontario
pan-Canadian Pharmaceutical Alliance / Cancer Care Ontario
Pan-Canadian Oncology Biosimilars Initiative
Pan-Canadian Oncology Biosimilars Initiative Action Plan
Pan-Canadian Oncology Biosimilars Summit Proceedings Report
Arthritis Consumer Experts
© 2000-2021
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.
Arthritis Consumer Experts
© 2000-2021
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.
Arthritis Consumer Experts
© 2000-2021
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.
